Omega Healthcare Investors Inc. (NYSE:ohi) declared a quarterly dividend on Friday, October 14th. Shareholders of record on Monday, October 31st will be given a dividend of 0.61 per share by the real estate investment trust on Tuesday, November 15th. This represents a $2.44 annualized dividend and a yield of 7.34%. The ex-dividend date of this dividend is Thursday, October 27th. This is a boost from Omega Healthcare Investors’s previous quarterly dividend of $0.60.
Omega Healthcare Investors (NYSE:OHI) opened at 33.22 on Monday. The company has a market capitalization of $6.43 billion, a price-to-earnings ratio of 20.85 and a beta of 0.65. Omega Healthcare Investors has a 12-month low of $26.96 and a 12-month high of $38.09. The firm’s 50-day moving average price is $35.31 and its 200 day moving average price is $34.40.
Omega Healthcare Investors (NYSE:OHI) last released its earnings results on Tuesday, August 2nd. The real estate investment trust reported $0.87 earnings per share for the quarter, topping the consensus estimate of $0.83 by $0.04. Omega Healthcare Investors had a return on equity of 7.44% and a net margin of 35.55%. The firm earned $228.80 million during the quarter, compared to analysts’ expectations of $181.59 million. During the same period in the prior year, the company earned $0.77 earnings per share. The company’s quarterly revenue was up 14.3% on a year-over-year basis. On average, analysts expect that Omega Healthcare Investors will post $3.39 earnings per share for the current year.
A number of research analysts have recently commented on the company. JMP Securities cut Omega Healthcare Investors from an “outperform” rating to a “market perform” rating in a research note on Thursday, August 18th. They noted that the move was a valuation call. BTIG Research assumed coverage on Omega Healthcare Investors in a research note on Thursday, August 25th. They issued a “neutral” rating for the company. Zacks Investment Research upgraded Omega Healthcare Investors from a “hold” rating to a “buy” rating and set a $40.00 price target for the company in a research note on Tuesday, August 9th. TheStreet upgraded Omega Healthcare Investors from a “hold” rating to a “buy” rating in a research note on Friday, August 5th. Finally, SunTrust Banks Inc. increased their price target on Omega Healthcare Investors from $38.00 to $42.00 and gave the company a “buy” rating in a research note on Thursday, August 4th. Three equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $36.96.
In other Omega Healthcare Investors news, insider Steven J. Insoft sold 5,500 shares of the stock in a transaction dated Monday, September 12th. The stock was sold at an average price of $35.91, for a total transaction of $197,505.00. Following the completion of the sale, the insider now directly owns 419,081 shares in the company, valued at approximately $15,049,198.71. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Craig M. Bernfield sold 43,942 shares of the stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $37.47, for a total value of $1,646,506.74. Following the sale, the director now owns 859,995 shares of the company’s stock, valued at $32,224,012.65. The disclosure for this sale can be found here. Company insiders own 4.54% of the company’s stock.
Hedge funds have recently modified their holdings of the stock. Point72 Asia Hong Kong Ltd purchased a new stake in shares of Omega Healthcare Investors during the second quarter valued at approximately $102,000. Nuveen Fund Advisors LLC purchased a new stake in shares of Omega Healthcare Investors during the second quarter valued at approximately $223,000. BOKF NA increased its stake in shares of Omega Healthcare Investors by 9.6% in the second quarter. BOKF NA now owns 10,051 shares of the real estate investment trust’s stock valued at $341,000 after buying an additional 879 shares in the last quarter. Jefferies Group LLC increased its stake in shares of Omega Healthcare Investors by 121.3% in the second quarter. Jefferies Group LLC now owns 12,590 shares of the real estate investment trust’s stock valued at $427,000 after buying an additional 6,902 shares in the last quarter. Finally, Pacad Investment Ltd. increased its stake in shares of Omega Healthcare Investors by 5.6% in the second quarter. Pacad Investment Ltd. now owns 15,100 shares of the real estate investment trust’s stock valued at $513,000 after buying an additional 800 shares in the last quarter. Institutional investors own 83.96% of the company’s stock.
Omega Healthcare Investors Company Profile
Omega Healthcare Investors, Inc (Omega) is a self-administered real estate investment trust (REIT). The Company invests in income producing healthcare facilities, long-term care facilities located throughout the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.
Receive News & Ratings for Omega Healthcare Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.